UBS O'Connor’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-50,000
Closed -$252K 300
2022
Q3
$252K Sell
50,000
-63,100
-56% -$3.74M ﹤0.01% 836
2022
Q2
$931K Buy
+113,100
New +$7.87M 0.01% 777
2022
Q1
Sell
-88,800
Closed -$253K 213
2021
Q4
$253K Buy
+88,800
New +$6.49M ﹤0.01% 718

Other funds holding THC

UBS O'Connor's THC Position: Q2 2018 in Review

UBS O'Connor sold out of Tenet Healthcare (THC) in Q2 2018, closing a stake of 50,000 shares — an estimated $1.21M sold.

UBS O'Connor first reported a position in THC in Q1 2017 and held it in 5 quarters. The position peaked at $7.89M in Q2 2017. 253 funds tracked by Wall St. Rank hold THC as of Q2 2018.

  • UBS O'Connor reported no remaining Tenet Healthcare position as of Q2 2018 after selling out during the quarter.
  • UBS O'Connor sold 50,000 Tenet Healthcare shares in Q2 2018, an estimated $1.21M.
  • UBS O'Connor first reported a position in Tenet Healthcare in Q1 2017 and held it in 5 quarters.
  • UBS O'Connor's Tenet Healthcare position peaked at $7.89M in Q2 2017.
  • 253 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2018.

Based on UBS O'Connor's 13F filing for Q2 2018, filed 14 Aug 2018.